Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UBT251 in Type 2 Diabetes Mellitus
NCT07659574Phase 3Recruiting
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 3 trial of UBT251 in type 2 diabetes mellitus (T2DM). Started Sep 2026; status: recruiting.
02
Drugs
UBT251
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07659574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07659574.